about
Comprehensive mutational profiling of core binding factor acute myeloid leukemia.Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing.MPAgenomics: an R package for multi-patient analysis of genomic markers.Nail-Patella Syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity.Applicability and Efficiency of NGS in Routine Diagnosis: In-Depth Performance Analysis of a Complete Workflow for CFTR Mutation AnalysisNext-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia.IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association.Vaginal Mucosal Homeostatic Response May Determine Pregnancy Outcome in Women With Bacterial Vaginosis: A Pilot StudyMelanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells.MicroRNAs in lymphoma, from diagnosis to targeted therapy.Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.Application of the cghRA framework to the genomic characterization of Diffuse Large B-Cell Lymphoma.BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.Waved aCGH: to smooth or not to smooth.Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.Corrigendum: Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn's Disease Patients.Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia.Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn's Disease PatientsGalectin-3 is a non-classic RNA binding protein that stabilizes the mucin MUC4 mRNA in the cytoplasm of cancer cells.Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.Quantification of JAK2V617F mutation by next-generation sequencing technology.SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.Dominance hierarchy arising from the evolution of a complex small RNA regulatory network.Peroxisome proliferator-activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut.Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial.Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.Sub-clonal analysis of the murine C1498 acute myeloid leukaemia cell line reveals genomic and immunogenic diversity.High-throughput sequencing in acute lymphoblastic leukemia: Follow-up of minimal residual disease and emergence of new clones.Multi-loci diagnosis of acute lymphoblastic leukaemia with high-throughput sequencing and bioinformatics analysis.The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma.Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.DiNAMO: highly sensitive DNA motif discovery in high-throughput sequencing data.
P50
Q33758306-9DE68974-1DC5-472A-A576-ED2709703FDFQ34106837-96DD7BB7-A337-4973-BB5D-D5A8660A72D2Q35178180-7A1DD30C-DFF4-4AEE-8197-6FEED14B683AQ35509594-D41F43E3-4C19-47BA-895E-3AD21A7D22B1Q35610918-5F6361B6-8819-48D2-A76A-3B94247D2BB8Q35930296-81F4659E-7803-48C8-AB2F-47B28FA27A29Q36356082-B92BBAF6-E69B-43D0-B320-A605F0D72DDBQ36561772-F50C27A4-4962-4BDF-8F6D-38DD85F023A6Q36566948-852F8C3A-73AD-4C13-9D3E-476DEE011C0BQ37134211-558A13E5-EDE8-4C87-8D7F-DAE2AFB3010AQ38121481-C78F840D-4ABC-4EFD-A240-AADEFC8EE331Q38732011-B3C0B2DE-682D-4179-B14D-135D7C694ED4Q38764010-6FBACFF3-DCCA-45AC-9FDB-962E34A3BF3AQ38798116-88C46D8C-E407-4786-AFF2-D696236BC378Q39051937-35351603-91B9-4A2B-99B4-46854D088956Q39356825-5A2AB465-9ACD-4759-AEF4-E710138D9C2BQ39762530-6CC84656-7118-4854-BDD4-60C9A5430CF5Q39986881-55101B2A-DD70-4F51-AA9B-A5B5475FAD5CQ40361991-6A355512-5A5B-4A22-BFE3-F67A292C942EQ40897451-C81AF75D-D75B-48F2-A10B-2F94A4655070Q41106646-41AC646C-3914-48C6-8D7C-4F5B5333E219Q41195432-07C024E4-1594-4BD8-88B7-114B0E10097CQ41964370-5D1C3979-A2C3-4242-B1A4-1FD36A993C50Q41991425-C23A5A46-D824-4754-A210-9DEFD72589A8Q42629781-53D442A2-FD8B-4129-800E-3DB9F78D6407Q44186784-3D718E22-F736-4EAD-BA9B-20DCA154AF95Q45941471-3A6E1C0C-0D0F-464E-828C-3E24999A1729Q46802549-5D4388C6-7499-4DDE-A1D4-FEA051028939Q47129950-6AB4B433-2EA3-445F-9EC6-7A8371629E3CQ47605552-0067A3F7-139A-40A5-A381-A8D4DC38FFA8Q47920784-07543448-0EC3-425A-972E-0625ACB2A3E6Q48177867-AFECAF07-6911-4EE4-BC1D-47E3487A68F4Q50066837-40BC2F8C-78EA-4C8C-B8F6-4999CCF2D542Q50111310-AA4A8111-1583-436A-979F-9A867757B5B4Q50230268-971C11F7-8B05-4F51-918C-FA57F8D08F02Q50953796-E605F9BB-7013-410B-B775-2C563517A1F1Q51008941-A6644E52-9D52-4C92-AEA9-BC442E14F342Q52887085-16031468-5356-4D02-998B-FC8F65662892Q52948207-90F40610-7AEC-48F5-82B3-1F48FF001EC1Q55339904-352B6B63-95F0-4A40-98D7-D0AD49DB4F4E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-8523-3708
@en
name
Martin Figeac
@ast
Martin Figeac
@en
Martin Figeac
@es
Martin Figeac
@nl
type
label
Martin Figeac
@ast
Martin Figeac
@en
Martin Figeac
@es
Martin Figeac
@nl
prefLabel
Martin Figeac
@ast
Martin Figeac
@en
Martin Figeac
@es
Martin Figeac
@nl
P106
P31
P496
0000-0001-8523-3708